NU51PS005162
Cooperative Agreement
Overview
Grant Description
Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments - According to Centers for Disease Control and Prevention (CDC), in 2018, Florida was ranked first for new diagnoses of acute and chronic hepatitis B and C and fourth for new acute hepatitis B cases, tenth in new acute hepatitis C cases, and 11th in new hepatitis A cases per 100,000 population in the United States (including District of Columbia).
In 2018, the Florida Department of Health (Department) reported 548 new hepatitis A diagnoses; 617 new acute hepatitis B diagnoses; 2,090 new chronic hepatitis B diagnoses; 435 new acute hepatitis C diagnoses, and 16,193 new chronic hepatitis C diagnoses, for a total of 19,883 new hepatitis diagnoses in Florida.
A robust surveillance system, identification of new cases of hepatitis, and linkage to care for those diagnosed with viral hepatitis are keys to the long-term goal of eliminating hepatitis in Florida. Florida Hepatitis Program intends to create tangible, measurable steps in addressing viral hepatitis statewide through the development of a Hepatitis Elimination Plan.
Florida's Hepatitis Program is drafting an elimination plan that outlines three key targets to help towards the elimination of hepatitis and indicators to assist with tracking progress between now and 2025. The program will engage community stakeholders and create an elimination plan working group who will provide input on specific goals, actions, and strategies, indicators, and recommendations that will make a meaningful impact in Florida's elimination planning.
Florida's Hepatitis Elimination Plan's goals include preventing new viral hepatitis infections, improving access and linkage to care, and improving outreach education and messaging. Florida's elimination plan will assist staff to focus on priority populations that are disproportionately affected by hepatitis A, hepatitis B, and/or hepatitis C, improved access to prevention and diagnosis, and access to treatment for hepatitis B and hepatitis C infection.
The Department will continue to improve data collection systems and increase outreach to gain a better understanding of the true burden of viral hepatitis in Florida and be able to systematically collect, analyze, interpret, and disseminate data to characterize trends and respond to outbreaks of hepatitis A, B, and C infection. We will establish a Hepatitis Outbreak Strike Team to rapidly respond to identified areas of concern. The strike team will have specific duties listed within their position descriptions, including communication with counties, local data analysis, and onsite technical assistance including vaccination and testing.
By the end of year one, the Department will have a written, comprehensive Hepatitis Outbreak Response Plan, building on existing collaborations and partnerships to address and mitigate disease transmission. The plan will have specific responses for hepatitis A, hepatitis B, and hepatitis C outbreaks.
To make progress toward the elimination of viral hepatitis in Florida, the Department and key partners and stakeholders must ensure that vaccination for hepatitis A and B is widely available for high-risk populations; testing for hepatitis is routinely available in high volume settings; treatment for hepatitis B and C is readily accessible through increased provider capacity; prevention education is disseminated to appropriate populations, and evidence-based interventions are implemented in clinical and non-clinical settings.
The Florida Department of Health has the infrastructure, capacity, and partnerships to leverage additional funding from CDC to support statewide advancement of efforts to eliminate hepatitis in our state.
In 2018, the Florida Department of Health (Department) reported 548 new hepatitis A diagnoses; 617 new acute hepatitis B diagnoses; 2,090 new chronic hepatitis B diagnoses; 435 new acute hepatitis C diagnoses, and 16,193 new chronic hepatitis C diagnoses, for a total of 19,883 new hepatitis diagnoses in Florida.
A robust surveillance system, identification of new cases of hepatitis, and linkage to care for those diagnosed with viral hepatitis are keys to the long-term goal of eliminating hepatitis in Florida. Florida Hepatitis Program intends to create tangible, measurable steps in addressing viral hepatitis statewide through the development of a Hepatitis Elimination Plan.
Florida's Hepatitis Program is drafting an elimination plan that outlines three key targets to help towards the elimination of hepatitis and indicators to assist with tracking progress between now and 2025. The program will engage community stakeholders and create an elimination plan working group who will provide input on specific goals, actions, and strategies, indicators, and recommendations that will make a meaningful impact in Florida's elimination planning.
Florida's Hepatitis Elimination Plan's goals include preventing new viral hepatitis infections, improving access and linkage to care, and improving outreach education and messaging. Florida's elimination plan will assist staff to focus on priority populations that are disproportionately affected by hepatitis A, hepatitis B, and/or hepatitis C, improved access to prevention and diagnosis, and access to treatment for hepatitis B and hepatitis C infection.
The Department will continue to improve data collection systems and increase outreach to gain a better understanding of the true burden of viral hepatitis in Florida and be able to systematically collect, analyze, interpret, and disseminate data to characterize trends and respond to outbreaks of hepatitis A, B, and C infection. We will establish a Hepatitis Outbreak Strike Team to rapidly respond to identified areas of concern. The strike team will have specific duties listed within their position descriptions, including communication with counties, local data analysis, and onsite technical assistance including vaccination and testing.
By the end of year one, the Department will have a written, comprehensive Hepatitis Outbreak Response Plan, building on existing collaborations and partnerships to address and mitigate disease transmission. The plan will have specific responses for hepatitis A, hepatitis B, and hepatitis C outbreaks.
To make progress toward the elimination of viral hepatitis in Florida, the Department and key partners and stakeholders must ensure that vaccination for hepatitis A and B is widely available for high-risk populations; testing for hepatitis is routinely available in high volume settings; treatment for hepatitis B and C is readily accessible through increased provider capacity; prevention education is disseminated to appropriate populations, and evidence-based interventions are implemented in clinical and non-clinical settings.
The Florida Department of Health has the infrastructure, capacity, and partnerships to leverage additional funding from CDC to support statewide advancement of efforts to eliminate hepatitis in our state.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Florida
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 90863% from $3,395 to $3,088,204.
Florida Department Of Health was awarded
Florida Hepatitis Elimination Plan: Surveillance & Prevention Funding
Cooperative Agreement NU51PS005162
worth $3,088,204
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in May 2021 with work to be completed primarily in Florida United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance.
The Cooperative Agreement was awarded through grant opportunity Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments.
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
5/1/21
Start Date
4/30/26
End Date
Funding Split
$3.1M
Federal Obligation
$0.0
Non-Federal Obligation
$3.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU51PS005162
Additional Detail
Award ID FAIN
NU51PS005162
SAI Number
NU51PS005162-861232506
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
L924BA1SEN75
Awardee CAGE
1HUA1
Performance District
FL-90
Senators
Marco Rubio
Rick Scott
Rick Scott
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $1,221,975 | 99% |
Modified: 9/5/25